Chemical Structure (Zavesca 01)
Zavesca Capsule
Product Images NDC 66215-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zavesca (NDC 66215-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actelion Pharmaceuticals Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (90 Capsule Carton)
Zavesca 100 mg is a medication that comes in capsule form, with each capsule containing 100mg of the active ingredient called migLUstat. Other inactive ingredients include povidone, sodium starch glycolate, gelatin, and titanium dioxide. The capsule shell is printed with black iron oxide and shellac. Dosage information can be found on the prescribing information. The medication should be stored between 20-25°C (68-77°F) with allowable excursions of 15-30°C (59-86°F). The manufacturer is Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company in South San Francisco, California, and it was made in Switzerland. The product comes in a package containing 90 capsules.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
